1211538-72-5

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 5-bromine-3-fluoropyridine-2-carboxylate is used as an intermediate in the synthesis of various pharmaceutical products. Its unique structure and reactivity allow for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
Methyl 5-bromine-3-fluoropyridine-2-carboxylate is used as an intermediate in the synthesis of agrochemicals, such as pesticides and herbicides. Its properties contribute to the development of effective and environmentally friendly solutions for agricultural challenges.
Used in Organic Synthesis:
Methyl 5-bromine-3-fluoropyridine-2-carboxylate is used as a building block in organic synthesis, allowing for the creation of a wide range of chemical compounds with various applications.
Used in Medicinal Chemistry Research:
Methyl 5-bromine-3-fluoropyridine-2-carboxylate is used as a research tool in medicinal chemistry, aiding scientists in understanding the structure-activity relationships of potential drug candidates and advancing the development of new therapeutic agents.
It is important to handle Methyl 5-bromine-3-fluoropyridine-2-carboxylate with caution, as it may have hazardous properties and requires proper handling and storage to ensure safety and prevent any potential health or environmental risks.

Upstream product

• 886373-28-0 5-bromo-3-fluoropyridine-2-carbonitrile 
• 67-56-1 methanol 
• 669066-91-5 5-bromo-3-fluoro-pyridine-2-carboxylic acid 

Downstream Products

• 1206968-92-4 (5-bromo-3-fluoropyridin-2-yl)methanol 
• 1256836-96-0 methyl 3-fluoro-5-hydroxypyridine-2-carboxylate 
• 1234616-19-3 (5-bromo-3-fluoropyridin-2-yl)methanamine 
• 1072448-08-8 3-amino-5-bromo-pyridine-2-carboxylic acid methyl ester 

Relevant academic research and scientific papers

5-FLUORONICOTINAMIDE DERIVATIVES AND USES THEREOF

Provided herein is a compound of Formula (I), or pharmaceutically acceptable salt thereof, wherein R1, Y, X, and n are defined herein. Also provided herein are compositions comprising a compound of Formula (I) or pharmaceutically acceptable salt thereof, and methods of using a compound of Formula (I) or pharmaceutically acceptable salt thereof, e.g., in the treatment of heart disease.

IMIDAZOLE AND TRIAZOLE CONTAINING BICYCLIC COMPOUNDS AS JAK INHIBITORS

The invention provides compounds of formula (I): or a pharmaceutically-acceptable salt thereof, wherein the variables are defined in the specification, that are inhibitors of JAK kinases, particularly JAK3. The invention also provides pharmaceutical compo

AZEPIN-2-ONE DERIVATIVES AS RSV INHIBITORS

The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

ARYLDIAZEPINE DERIVATIVES AS RSV INHIBITORS

The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, esters, or prodrugs thereof, which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULPHUR CONTAINING SUBSTITUENTS

Compounds of formula (I) wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, can be used as insecticides and can be prepared in a manner known per se.

FATTY ACID SYNTHASE INHIBITORS

This invention relates to novel spirocyclic piperidines according to Formula (I) which are inhibitors of fatty acid synthase (FAS), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of cancers.

LXR MODULATORS

The present invention provides compounds of Formula I and Formula II: or pharmaceutically acceptable salts or solvates thereof, as modulators of liver X receptors (LXRs), and compositions comprising any of such novel compounds and methods of use thereof. These compounds are useful as medicaments for treatment and/or prophylaxis for diseases or conditions related to activity of LXRs.